Sign In
Buy CHRS
$1.46
-0.0200 (-1.35%)
At Close: Jun 23, 2026
Does Coherus BioSciences, Inc.’s (NASDAQ:CHRS) CEO Pay Matter?
01:31pm, Saturday, 04'th Apr 2020
Denny Lanfear has been the CEO of Coherus BioSciences, Inc. (NASDAQ:CHRS) since 2010. This report will, first, examine...
Amgen (AMGN) Receives a Hold from Mizuho Securities
05:25pm, Thursday, 02'nd Apr 2020
Mizuho Securities analyst Salim Syed maintained a Hold rating on Amgen (AMGN) today and set a price target of $215.00. The company's shares closed last
Global Biosimilars Market (2020 to 2025) - New Indications and the Patent Expiry of Biologic Products Present Lucrative Opportunities
05:45pm, Wednesday, 01'st Apr 2020
The "Biosimilars Market by Product (Insulin, Interferon, Etanercept, Infliximab, Rituximab, Glucagon, Calcitonin), Manufacturing (In-house, Contract) & Indication (Oncology, Chronic Disease, Blood Dis
Mizuho Securities Keeps Their Buy Rating on Unity Biotechnology (UBX)
11:36pm, Tuesday, 31'st Mar 2020
In a report released today, Salim Syed from Mizuho Securities maintained a Buy rating on Unity Biotechnology (UBX), with a price target of $33.00. The
Mizuho Securities Keeps Their Buy Rating on Unity Biotechnology (UBX)
11:36pm, Tuesday, 31'st Mar 2020
In a report released today, Salim Syed from Mizuho Securities maintained a Buy rating on Unity Biotechnology (UBX – Research
3,594 Shares in Coherus Biosciences Inc (NASDAQ:CHRS) Acquired by Great West Life Assurance Co. Can
10:44am, Tuesday, 31'st Mar 2020
Great West Life Assurance Co. Can acquired a new position in shares of Coherus Biosciences Inc (NASDAQ:CHRS) in the 4th quarter, according to the company in its most recent filing with the SEC. The fu
Coherus Biosciences Inc (NASDAQ:CHRS) Shares Acquired by Alliancebernstein L.P.
08:30am, Tuesday, 31'st Mar 2020
Alliancebernstein L.P. lifted its holdings in shares of Coherus Biosciences Inc (NASDAQ:CHRS) by 293.0% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional
Biosimilars Market by Product, Manufacturing & Indication and Region - Global Forecast to 2025
03:13pm, Monday, 30'th Mar 2020
Dublin, March 30, 2020 -- The "Biosimilars Market by Product (Insulin, Interferon, Etanercept, Infliximab, Rituximab, Glucagon, Calcitonin), Manufacturing (In-house,.
Blueshift Asset Management LLC Takes $237,000 Position in Coherus Biosciences Inc (NASDAQ:CHRS)
10:40am, Saturday, 28'th Mar 2020
Blueshift Asset Management LLC purchased a new stake in Coherus Biosciences Inc (NASDAQ:CHRS) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exch
Coherus Biosciences (NASDAQ:CHRS) Raised to Sell at BidaskClub
06:42am, Friday, 27'th Mar 2020
Coherus Biosciences (NASDAQ:CHRS) was upgraded by investment analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a report released on Friday, BidAskClub reports. Several o
Is Coherus BioSciences (CHRS) Stock a Solid Choice Right Now?
12:34pm, Thursday, 26'th Mar 2020
Coherus BioSciences (CHRS) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Is Coherus BioSciences (CHRS) Stock a Solid Choice Right Now?
12:34pm, Thursday, 26'th Mar 2020
Coherus BioSciences (CHRS) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Biogen (BIIB) Gets a Hold Rating from Mizuho Securities
11:31am, Thursday, 26'th Mar 2020
Mizuho Securities analyst Salim Syed maintained a Hold rating on Biogen (BIIB) today and set a price target of $316.00. The company's shares closed last
Biogen (BIIB) Gets a Hold Rating from Mizuho Securities
11:31am, Thursday, 26'th Mar 2020
Mizuho Securities analyst Salim Syed maintained a Hold rating on Biogen (BIIB – Research Report) today and set a price
